Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
1.795
-0.205 (-10.25%)
At close: May 13, 2025, 4:00 PM
1.810
+0.015 (0.84%)
Pre-market: May 14, 2025, 8:51 AM EDT

Sana Biotechnology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Selling, General & Admin
59.2664.0473.367.0650.4128.27
Upgrade
Research & Development
155.64207.43253.6204.37274.66232.09
Upgrade
Operating Expenses
214.9271.47326.9271.43325.07260.36
Upgrade
Operating Income
-214.9-271.47-326.9-271.43-325.07-260.36
Upgrade
Interest & Investment Income
8.4310.479.943.760.680.75
Upgrade
Other Non Operating Income (Expenses)
0.03--0.05-0.670.310.1
Upgrade
EBT Excluding Unusual Items
-206.43-261-317.01-268.34-324.09-259.51
Upgrade
Asset Writedown
-6.4-6.4-7.01-4.5--
Upgrade
Other Unusual Items
4.160.6440.773.36-31.84-25.79
Upgrade
Pretax Income
-208.67-266.76-283.26-269.48-355.93-285.31
Upgrade
Net Income
-208.67-266.76-283.26-269.48-355.93-285.31
Upgrade
Net Income to Common
-208.67-266.76-283.26-269.48-355.93-285.31
Upgrade
Shares Outstanding (Basic)
23623119518816613
Upgrade
Shares Outstanding (Diluted)
23623119518816613
Upgrade
Shares Change (YoY)
17.36%18.68%3.29%13.16%1178.88%165.43%
Upgrade
EPS (Basic)
-0.88-1.16-1.46-1.43-2.14-21.92
Upgrade
EPS (Diluted)
-0.88-1.16-1.46-1.43-2.14-21.92
Upgrade
Free Cash Flow
-223.9-256.58-273.61-310.93-280.92-161.85
Upgrade
Free Cash Flow Per Share
-0.95-1.11-1.41-1.65-1.69-12.44
Upgrade
EBITDA
-199.49-255.97-309.36-255.8-314-254.44
Upgrade
D&A For EBITDA
15.415.517.5415.6311.075.92
Upgrade
EBIT
-214.9-271.47-326.9-271.43-325.07-260.36
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q